Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis

Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data

(2015) Lesley A. Stewart et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use

(2015) Jayne F. Tierney et al.   PLOS MEDICINE

Preterm birth–associated neurodevelopmental impairment estimates at regional and global levels for 2010

(2013) Hannah Blencowe et al.   PEDIATRIC RESEARCH

Magnesium sulphate at 30 to 34 weeks’ gestational age: neuroprotection trial (MAGENTA) - study protocol

(2013) Caroline A Crowther et al.   BMC Pregnancy and Childbirth

Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review

(2013) Emily S Bain et al.   BMC Pregnancy and Childbirth

National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications

(2012) Hannah Blencowe et al.   LANCET

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Christopher J L Murray et al.   LANCET

Committee Opinion No. 455: Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

(2010)   OBSTETRICS AND GYNECOLOGY

An overview of mortality and sequelae of preterm birth from infancy to adulthood

(2008) Saroj Saigal et al.   LANCET

A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy

(2008) Dwight J. Rouse et al.   NEW ENGLAND JOURNAL OF MEDICINE